Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RO7443904 |
Synonyms | |
Therapy Description |
RO7443904 is a bispecific antibody that targets both CD19 and CD28, resulting in cross-linking of CD28-positive T-cells to CD19-expressing tumor cells, potentially leading to enhanced cytotoxic response against CD19-positive tumor cells (NCI Drug Dictionary). |